JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 28, 2004; DOI: 10.1124/jpet.104.070003


0022-3565/04/3111-8-13$20.00
JPET 311:8-13, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.070003v1
311/1/8    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tejero-Taldo, M. I.
Right arrow Articles by Weglicki, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tejero-Taldo, M. I.
Right arrow Articles by Weglicki, W. B.

CARDIOVASCULAR

N-Methyl-D-aspartate Receptor Blockade Inhibits Cardiac Inflammation in the Mg2+-Deficient Rat

M. Isabel Tejero-Taldo, Joanna J. Chmielinska, Grace Gonzalez, I. Tong Mak, and William B. Weglicki

Division of Experimental Medicine, Departments of Biochemistry and Molecular Biology (M.I.T., J.J.C., I.T.M., W.B.W.), Neurosurgery (G.G.), and Medicine (W.B.W.), George Washington University Medical Center, Washington, DC

Elevated plasma levels of the neuropeptide substance P (SP) precede the perivascular inflammatory infiltrate seen in hearts of Mg2+-deficient (MgD) animals. The N-methyl-D-aspartate (NMDA) receptor is found in neurons, and activation of this receptor participates in SP release; under normal circumstances, this release can be blocked by Mg2+. Therefore, we reasoned that blockade of the NMDA receptor with dizolcipine maleate (a noncompetitive NMDA receptor antagonist) would prevent SP release from C-fibers due to MgD. In this study, animals were implanted with slow-release pellets containing dizolcipine or placebo and were fed with diet sufficient in Mg2+ or deficient with only 9% of USDA-recommended Mg2+. SP immunostaining of dorsal root ganglia showed a time-dependent depletion of SP in the MgD animals, with a dramatic decrease of SP by week 2; this depletion was prevented by pretreatment with dizolcipine maleate. The significant increase in plasma prostaglandin E2 levels during MgD was prevented by dizolcipine, and the loss of total red blood cell glutathione content was significantly attenuated by NMDA blockade after 3 weeks of MgD (p < 0.01 versus controls). Immunohistochemical and Western blot analyses of ventricular tissue demonstrated that NMDA receptor blockade abolished MgD-related increase of endothelium adhesion molecule CD54 (weeks 1 and 2; p < 0.05), and of monocyte/macrophage surface protein CD11b expression (week 3; p < 0.05). We conclude that NMDA receptor blockade with dizolcipine maleate prevented SP depletion and reduced perivascular inflammatory infiltrates, thus decreasing cardiac injury due to Mg2+ deficiency.


Received April 15, 2004; accepted May 27, 2004.

Address correspondence to: Dr. M. Isabel Tejero, Division of Experimental Medicine, Department of Biochemistry and Molecular Biology, George Washington University Medical Center, 2300 I St., NW, Washington, DC 20037. E-mail: phymit{at}gwumc.edu




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. T. Weber, W. B. Weglicki, and R. U. Simpson
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium
Cardiovasc Res, February 15, 2009; 81(3): 500 - 508.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.